Published by Josh White on 3rd November 2023
(Sharecast News) - Biotechnology firm Sareum announced on Friday that it has received a notice of allowance from the Japan Patent Office for a patent associated with SDC-1801, its primary TYK2/JAK1 kinase inhibitor.
URL: http://www.digitallook.com/dl/news/story/33884215/...